FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...